MT-TT Gene Parkinson Disease Susceptibility Genetic Test
At DNA Labs UAE, we offer the MT-TT Gene Parkinson Disease Susceptibility Genetic Test. This test aims to identify an individual’s susceptibility to Parkinson’s disease by analyzing the MT-TT gene.
Test Components and Price
The MT-TT Gene Parkinson Disease Susceptibility Genetic Test is priced at 4400.0 AED. The test can be conducted using blood or extracted DNA, or by using one drop of blood on an FTA card.
Report Delivery
The test results are typically delivered within 3 to 4 weeks.
Method
The MT-TT Gene Parkinson Disease Susceptibility Genetic Test utilizes NGS (Next-Generation Sequencing) technology for analysis.
Test Type
The MT-TT Gene Parkinson Disease Susceptibility Genetic Test falls under the category of Neurological Disorders.
Doctor and Test Department
The test is performed by a Neurologist in the Genetics department.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is undergoing the MT-TT Gene Parkinson Disease Susceptibility Genetic Test. Additionally, a genetic counseling session is conducted to create a pedigree chart of family members affected by MT-TT Gene Parkinson Disease.
Test Details
Parkinson’s disease is a neurodegenerative disorder that affects movement, causing symptoms such as tremors, stiffness, and difficulties with balance and coordination. While the exact cause of Parkinson’s disease is unknown, genetic and environmental factors are believed to contribute to its development.
The MT-TT gene is one of the genes associated with Parkinson’s disease susceptibility. This gene encodes a transfer RNA (tRNA) molecule involved in protein synthesis within the mitochondria, which are responsible for producing energy within cells.
The MT-TT Gene Parkinson Disease Susceptibility Genetic Test utilizes NGS technology to identify variations or mutations within the MT-TT gene. These variations or mutations can increase an individual’s susceptibility to Parkinson’s disease.
It is important to note that this genetic test is not a diagnostic test for Parkinson’s disease. It provides information about an individual’s genetic risk but does not confirm the presence or absence of the disease. Other factors, such as environmental exposures and lifestyle choices, also contribute to the development of Parkinson’s disease.
If you are considering the MT-TT Gene Parkinson Disease Susceptibility Genetic Test, it is recommended to consult with a healthcare professional or genetic counselor. They can provide guidance, explain the benefits and limitations of the test, and help interpret the results in the context of your individual health history.
| Test Name | MT-TT Gene Parkinson disease susceptibility to MT-TT related Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MT-TT Gene Parkinson disease, susceptibility to, MT-TT related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MT-TT Gene Parkinson disease, susceptibility to, MT-TT related |
| Test Details |
Parkinson’s disease is a neurodegenerative disorder that affects movement and can lead to tremors, stiffness, and difficulty with balance and coordination. While the exact cause of Parkinson’s disease is unknown, both genetic and environmental factors are believed to play a role in its development. The MT-TT gene is one of the many genes that have been associated with Parkinson’s disease susceptibility. The MT-TT gene is responsible for encoding a transfer RNA (tRNA) molecule that is involved in protein synthesis within the mitochondria, the energy-producing structures within cells. A genetic test that focuses on the MT-TT gene can help identify variations or mutations within this gene that may increase an individual’s susceptibility to Parkinson’s disease. This test is typically performed using next-generation sequencing (NGS) technology, which allows for the simultaneous analysis of multiple genes or regions of the genome. By identifying specific variations or mutations in the MT-TT gene, healthcare providers can assess an individual’s risk of developing Parkinson’s disease. This information can be useful in terms of early detection, personalized treatment plans, and genetic counseling for individuals and their families. It is important to note that genetic testing for Parkinson’s disease susceptibility is not a diagnostic test. It provides information about an individual’s genetic risk but does not confirm the presence or absence of the disease. Other factors, such as environmental exposures and lifestyle choices, also contribute to the development of Parkinson’s disease. If you are considering a genetic test for Parkinson’s disease susceptibility, it is recommended to consult with a healthcare professional or genetic counselor who can provide guidance, explain the benefits and limitations of the test, and help interpret the results in the context of your individual health history. |
